Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Overview

  • Founded
  • 1996
Founded
  • Status
  • Public
  • Employees
  • 628
Employees
  • Stock Symbol
  • 01349
Stock Symbol
  • Investments
  • 1
  • Share Price
  • $0.65
  • (As of Friday Closing)

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical General Information

Description

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd is engaged in research, development, manufacturing, and sale of biopharmaceutical products. Its product portfolio includes ALA (Aminolevulinic acid Hydrochloride); FuMeiDa and Libord. Geographically, it derives revenue from Mainland China.

Contact Information

Website
www.fd-zj.com
Ownership Status
Publicly Held
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Stock Exchange
HKG
Primary Office
  • No.308 Cailun Road
  • Z.J.Hi-tech Park
  • Shanghai, 201210
  • China
+86 00000000000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.65 $0.64 $0.46 - $1.19 $681M 1.04B 2.15M $0.02

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Financials Summary

In Thousands,
USD
TTM 31-Dec-2020 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 324,741 324,741 479,773 411,834
Revenue 120,690 120,690 148,965 112,141
EBITDA 33,709 33,709 44,917 23,350
Net Income 23,834 23,834 32,904 16,950
Total Assets 382,762 382,762 223,649 213,649
Total Debt 2,081 2,081 21,590 21,805
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Shanghai Fudan-Zhangjiang Bio-Pharmaceutical‘s full profile, request access.

Request a free trial

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Executive Team (2)

Name Title Board Seat Contact Info
Haibo Wang Chairman, Executive Director & General Manager
Yan Xue Company Secretary & Authorized Representative
To view Shanghai Fudan-Zhangjiang Bio-Pharmaceutical’s complete executive team members history, request access »

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Board Members (1)

Name Representing Role Since
00000 0000 Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Chairman, Executive Director & General Manager 000 0000
To view Shanghai Fudan-Zhangjiang Bio-Pharmaceutical’s complete board members history, request access »

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Shanghai Fudan-Zhangjiang Bio-Pharmaceutical‘s full profile, request access.

Request a free trial

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000 00000000000 22-Feb-2017 000000000 000 Biotechnology
To view Shanghai Fudan-Zhangjiang Bio-Pharmaceutical’s complete investments history, request access »

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
000000 00000000000 22-Feb-2017 000000000 000 Completed
  • 00000000 00000-000
To view Shanghai Fudan-Zhangjiang Bio-Pharmaceutical’s complete exits history, request access »